A Phase IIIb/IV Randomized, Controlled, Double-blind, Double-dummy, Parallel Group Study to Compare the Efficacy of Fidaxomicin to Vancomycin in the Sustained Clinical Cure of Clostridium Difficile Infection in Adults Receiving Immunosuppressive Therapy

Trial Profile

A Phase IIIb/IV Randomized, Controlled, Double-blind, Double-dummy, Parallel Group Study to Compare the Efficacy of Fidaxomicin to Vancomycin in the Sustained Clinical Cure of Clostridium Difficile Infection in Adults Receiving Immunosuppressive Therapy

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 20 Nov 2015

At a glance

  • Drugs Fidaxomicin (Primary) ; Vancomycin
  • Indications Clostridium infections
  • Focus Therapeutic Use
  • Acronyms Freedom
  • Sponsors Astellas Pharma Europe Ltd
  • Most Recent Events

    • 01 Apr 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 24 Jan 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01775397).
    • 24 Jan 2013 Planned End Date changed from 9 Oct 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top